Scientists probe why cystinosis treatment fails to protect the brain
NCT ID NCT02012114
Summary
This study aimed to understand how consistently patients with cystinosis take their cysteamine medication and how that affects cystine levels in their bodies and potential brain complications. Researchers followed 65 patients over two years, using electronic monitors to track pill-taking and brain scans to look for cystine buildup. The goal was to learn if the drug reaches the brain and how treatment adherence influences long-term health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTINOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospices Civils de Lyon
Lyon, 69002, France
Conditions
Explore the condition pages connected to this study.